Behavioral Therapy for Children and Adolescents With Tourette Syndrome
NCT ID: NCT03621059
Last Updated: 2018-08-08
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
46 participants
Study Classification
INTERVENTIONAL
Study Start Date
2015-01-01
Study Completion Date
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Tourette Syndrome (TS) is a common neuropsychiatric disorder in childhood and adolescence, and often comorbid with psychiatric comorbidity. Antipsychotic medications are usually the first choices, but may associate with adverse effects. Behavioral intervention for TS has been shown to be an effective treatment for children and adolescents, yet have not been performed and evaluated using control trails in Taiwan.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
NCT06613126
Tourette Syndrome
Tic Disorder
Neurodevelopmental Disorder
RECRUITING
NA
Group Intervention for Children With Chronic Tics Syndrome or Tourette Syndrome: CBIT vs Psycho-Educational Intervention
NCT02407951
Tourette Syndrome
Motor or Vocal Tic Disorder, Chronic
UNKNOWN
NA
Efficacy of Psychotherapy Treatment of Children With Tics
NCT02144870
Tic-Disorder
UNKNOWN
NA
Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome
NCT02882490
Tourette Syndrome
Behavioral Problem
UNKNOWN
NA
Efficacy of a Habit Reversal Treatment on Tic-symptoms
NCT02190383
Tic-Disorder
UNKNOWN
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
TS is a common neuropsychiatric disorder in childhood and adolescence, and often comorbid with psychiatric comorbidity. Antipsychotic medications are usually the first choices, but may associate with adverse effects. Behavioral intervention for TS has been shown to be an effective treatment for children and adolescents, yet have not been performed and evaluated using control trails in Taiwan. This study therefore was to evaluate the efficacy of a comprehensive behavioral intervention therapy on improving tics and tic-related impairment for children and adolescents with Tourette syndrome.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Tourette Syndrome
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
A collection of behavioral skills named as Comprehensive Behavioral Intervention (CBIT) for Tics had been found to be effective (Piacentini et al., 2010).The major components of CBIT includes psychoeducation of tics, habit reversal training (HRT), function-based interventions, and relaxation training (Piacentini et al., 2010).The HRT consists of several therapeutic activities, including awareness training (i.e., observing the premonitory urge or other signs preceding the occurrence of a tic), competing response training (i.e., engaging in a voluntary behavior that is physically incompatible with the tic to manage the premonitory urge), self-monitoring of tics and relaxation training (Himle et al., 2006).
Primary Study Purpose
TREATMENT
Blinding Strategy
SINGLE
Participants
Eligible children were randomly assigned by sealed envelope to either intervention or control group. Several methods were used to maintain the treatment blindly, including segregation of assessment and treatment staff and instructions to children and parents to avoid discussions of treatment assignment with the independent evaluators.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behavioral Therapy with TS
habit reversal training (HRT)
Group Type
EXPERIMENTAL
habit reversal training (HRT)
Intervention Type
BEHAVIORAL
The intervention group received 4 sessions during 3months of behavior intervention and then, were reassessed at 3 and 6 months following treatment.
Pyridoxine(50mg)
observational
observational and usual care Pyridoxine(50mg)
Group Type
NO_INTERVENTION
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
habit reversal training (HRT)
The intervention group received 4 sessions during 3months of behavior intervention and then, were reassessed at 3 and 6 months following treatment.
Pyridoxine(50mg)
Intervention Type
BEHAVIORAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* DSM-5 Diagnostic Criteria For Tourette Syndrome
* Patients aged from 6-15 years who were diagnosed with TS or CTD,
* Never received any pharmacological treatment
* Ability to understand the study purpose and/or provide consent for participation independently and via a caregiver serving as a proxy
* Patients aged from 6-15 years who were diagnosed with TS or CTD,
* Never received any pharmacological treatment
* Ability to understand the study purpose and/or provide consent for participation independently and via a caregiver serving as a proxy
Exclusion Criteria
* Have been diagnosed with another mental illness,
* Had no physical or medical condition,
* Had been received CBIT or cognitive behavior therapy before.
* Had no physical or medical condition,
* Had been received CBIT or cognitive behavior therapy before.
Minimum Eligible Age
6 Years
Maximum Eligible Age
15 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chang, Hsiu-Ju
professor
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hsiu-ju Chang, PHD
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University
References
Explore related publications, articles, or registry entries linked to this study.
Bitsko RH, Holbrook JR, Visser SN, Mink JW, Zinner SH, Ghandour RM, Blumberg SJ. A national profile of Tourette syndrome, 2011-2012. J Dev Behav Pediatr. 2014 Jun;35(5):317-22. doi: 10.1097/DBP.0000000000000065.
Reference Type
RESULT
Robertson MM, Eapen V, Cavanna AE. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J Psychosom Res. 2009 Dec;67(6):475-83. doi: 10.1016/j.jpsychores.2009.07.010.
Reference Type
RESULT
Wang HS, Kuo MF. Tourette's syndrome in Taiwan: an epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev. 2003 Dec;25 Suppl 1:S29-31. doi: 10.1016/s0387-7604(03)90005-2.
Reference Type
RESULT
Chou IC, Lin HC, Lin CC, Sung FC, Kao CH. Tourette syndrome and risk of depression: a population-based cohort study in Taiwan. J Dev Behav Pediatr. 2013 Apr;34(3):181-5. doi: 10.1097/DBP.0b013e3182829f2b.
Reference Type
RESULT
King RA, Scahill L. Emotional and behavioral difficulties associated with Tourette syndrome. Adv Neurol. 2001;85:79-88. No abstract available.
Reference Type
RESULT
Robertson MM, Banerjee S, Eapen V, Fox-Hiley P. Obsessive compulsive behaviour and depressive symptoms in young people with Tourette syndrome. A controlled study. Eur Child Adolesc Psychiatry. 2002 Dec;11(6):261-5. doi: 10.1007/s00787-002-0301-3.
Reference Type
RESULT
Rizzo R, Gulisano M, Pellico A, Cali PV, Curatolo P. Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities. J Child Neurol. 2014 Oct;29(10):1383-9. doi: 10.1177/0883073814534317. Epub 2014 May 14.
Reference Type
RESULT
Leckman JF, Zhang H, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS, Peterson BS. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics. 1998 Jul;102(1 Pt 1):14-9. doi: 10.1542/peds.102.1.14.
Reference Type
RESULT
Elstner K, Selai CE, Trimble MR, Robertson MM. Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome. Acta Psychiatr Scand. 2001 Jan;103(1):52-9. doi: 10.1034/j.1600-0447.2001.00147.x.
Reference Type
RESULT
Shprecher D, Kurlan R. The management of tics. Mov Disord. 2009 Jan 15;24(1):15-24. doi: 10.1002/mds.22378.
Reference Type
RESULT
Muller-Vahl KR, Buddensiek N, Geomelas M, Emrich HM. The influence of different food and drink on tics in Tourette syndrome. Acta Paediatr. 2008 Apr;97(4):442-6. doi: 10.1111/j.1651-2227.2008.00675.x. Epub 2008 Feb 27.
Reference Type
RESULT
Garcia-Lopez R, Perea-Milla E, Garcia CR, Rivas-Ruiz F, Romero-Gonzalez J, Moreno JL, Faus V, Aguas Gdel C, Diaz JC. New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6. Trials. 2009 Mar 10;10:16. doi: 10.1186/1745-6215-10-16.
Reference Type
RESULT
Scahill L, Erenberg G, Berlin CM Jr, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J; Tourette Syndrome Association Medical Advisory Board: Practice Committee. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006 Apr;3(2):192-206. doi: 10.1016/j.nurx.2006.01.009.
Reference Type
RESULT
Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, Strand G, Stern JS, Termine C, Hoekstra PJ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96. doi: 10.1007/s00787-011-0163-7.
Reference Type
RESULT
Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry. 2001 Jan;62(1):50-6. doi: 10.4088/jcp.v62n0111.
Reference Type
RESULT
Sallee FR, Gilbert DL, Vinks AA, Miceli JJ, Robarge L, Wilner K. Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission. J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):902-7. doi: 10.1097/01.CHI.0000046897.27264.46.
Reference Type
RESULT
Bressan RA, Jones HM, Pilowsky LS. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity. J Psychopharmacol. 2004 Mar;18(1):124-7. doi: 10.1177/0269881104040251.
Reference Type
RESULT
Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):330-6. doi: 10.1097/00004583-200203000-00013.
Reference Type
RESULT
Du YS, Li HF, Vance A, Zhong YQ, Jiao FY, Wang HM, Wang MJ, Su LY, Yu DL, Ma SW, Wu JB. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry. 2008 Sep;42(9):807-13. doi: 10.1080/00048670802277222.
Reference Type
RESULT
Ho CS, Chen HJ, Chiu NC, Shen EY, Lue HC. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc. 2009 Oct;108(10):788-93. doi: 10.1016/S0929-6646(09)60406-X.
Reference Type
RESULT
Kim DD, Warburton DER, Wu N, Barr AM, Honer WG, Procyshyn RM. Effects of physical activity on the symptoms of Tourette syndrome: A systematic review. Eur Psychiatry. 2018 Feb;48:13-19. doi: 10.1016/j.eurpsy.2017.11.002. Epub 2018 Jan 10.
Reference Type
RESULT
Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, Ginsburg GS, Deckersbach T, Dziura J, Levi-Pearl S, Walkup JT. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010 May 19;303(19):1929-37. doi: 10.1001/jama.2010.607.
Reference Type
RESULT
Dutta N, Cavanna AE. The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review. Funct Neurol. 2013 Jan-Mar;28(1):7-12.
Reference Type
RESULT
Himle MB, Woods DW, Piacentini JC, Walkup JT. Brief review of habit reversal training for Tourette syndrome. J Child Neurol. 2006 Aug;21(8):719-25. doi: 10.1177/08830738060210080101.
Reference Type
RESULT
Azrin NH, Nunn RG. Habit-reversal: a method of eliminating nervous habits and tics. Behav Res Ther. 1973 Nov;11(4):619-28. doi: 10.1016/0005-7967(73)90119-8. No abstract available.
Reference Type
RESULT
Woods DW, Miltenberger RG. Habit reversal: a review of applications and variations. J Behav Ther Exp Psychiatry. 1995 Jun;26(2):123-31. doi: 10.1016/0005-7916(95)00009-o.
Reference Type
RESULT
Watson TS, Sterling HE. Brief functional analysis and treatment of a vocal tic. J Appl Behav Anal. 1998 Fall;31(3):471-4. doi: 10.1901/jaba.1998.31-471.
Reference Type
RESULT
Blount TH, Lockhart AL, Garcia RV, Raj JJ, Peterson AL. Intensive outpatient comprehensive behavioral intervention for tics: A case series. World J Clin Cases. 2014 Oct 16;2(10):569-77. doi: 10.12998/wjcc.v2.i10.569.
Reference Type
RESULT
Deckersbach T, Rauch S, Buhlmann U, Wilhelm S. Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther. 2006 Aug;44(8):1079-90. doi: 10.1016/j.brat.2005.08.007. Epub 2005 Nov 2.
Reference Type
RESULT
Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, Chang S, Liu H, Dziura J, Walkup JT, Scahill L. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry. 2012 Aug;69(8):795-803. doi: 10.1001/archgenpsychiatry.2011.1528.
Reference Type
RESULT
Abramovitch A, Reese H, Woods DW, Peterson A, Deckersbach T, Piacentini J, Scahill L, Wilhelm S. Psychometric Properties of a Self-Report Instrument for the Assessment of Tic Severity in Adults With Tic Disorders. Behav Ther. 2015 Nov;46(6):786-96. doi: 10.1016/j.beth.2015.06.002. Epub 2015 Jun 18.
Reference Type
RESULT
Storch EA, Murphy TK, Geffken GR, Sajid M, Allen P, Roberti JW, Goodman WK. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005 Dec;17(4):486-91. doi: 10.1037/1040-3590.17.4.486.
Reference Type
RESULT
Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):566-73. doi: 10.1097/00004583-198907000-00015.
Reference Type
RESULT
Azrin NH, Peterson AL. Habit reversal for the treatment of Tourette syndrome. Behav Res Ther. 1988;26(4):347-51. doi: 10.1016/0005-7967(88)90089-7. No abstract available.
Reference Type
RESULT
Yates R, Edwards K, King J, Luzon O, Evangeli M, Stark D, McFarlane F, Heyman I, Ince B, Kodric J, Murphy T. Habit reversal training and educational group treatments for children with tourette syndrome: A preliminary randomised controlled trial. Behav Res Ther. 2016 May;80:43-50. doi: 10.1016/j.brat.2016.03.003. Epub 2016 Mar 23.
Reference Type
RESULT
Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry. 2018 Mar 27;9:100. doi: 10.3389/fpsyt.2018.00100. eCollection 2018.
Reference Type
RESULT
Woods DW, Twohig MP, Flessner CA, Roloff TJ. Treatment of vocal tics in children with Tourette syndrome: investigating the efficacy of habit reversal. J Appl Behav Anal. 2003 Spring;36(1):109-12. doi: 10.1901/jaba.2003.36-109.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ju07310520
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Extinction Learning in Youth With Tourette Syndrome
NCT03765463
COMPLETED
NA
Group Therapy Versus Individual Therapy for Tourette Syndrome and Chronic Tic Disorder
NCT04594044
COMPLETED
NA
Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder
NCT06385535
RECRUITING
NA
Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
NCT04449003
COMPLETED
Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics
NCT06825520
RECRUITING
NA
Behavioral Therapy for Tourette Syndrome
NCT03019731
COMPLETED
NA
The Effect and Safety of Plum-blossom Needle for Tourette Syndrome
NCT02403258
UNKNOWN
NA
Exploring the Role of Neuroactive Steroids in Tourette Syndrome
NCT05281445
UNKNOWN
NA
Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome
NCT02732496
COMPLETED
NA
Behavior Therapy for Irritability in Autism
NCT04654260
ACTIVE_NOT_RECRUITING
NA
Board Game Project for Adolescents with Tourette Syndrome
NCT05566236
COMPLETED
NA
Schema, Emotion and Behavior-Based Therapy for School Children
NCT02010086
COMPLETED
NA
Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial
NCT00789932
COMPLETED
PHASE1/PHASE2
Activity in Tourette Syndrome
NCT02153463
COMPLETED
NA
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
NCT01631851
COMPLETED
NA
Effects of Family Work Shop for Children With Developmental Delays: a Randomized Trial
NCT03209453
UNKNOWN
NA
The Therapeutic Effects of Barkley's Parenting Management Program for Taiwanese School-Aged Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT00946582
UNKNOWN
PHASE1
Treatment Outcome of Combined Virtual Tic Training in Children and Adolescents With a Chronic Tic Disorder
NCT04678180
ACTIVE_NOT_RECRUITING
NA
Gilles de la Tourette Syndrome (TS) and Seasonality
NCT04076852
TERMINATED
Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism
NCT01983189
TERMINATED
PHASE2
Treatment of Social Anxiety Disorder and Selective Mutism
NCT02554929
COMPLETED
NA
Parent-mediated and Telehealth Intervention for Children With Autism Spectrum Disorder
NCT05810675
UNKNOWN
NA
Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth
NCT03932032
ACTIVE_NOT_RECRUITING
NA
Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism
NCT00004449
COMPLETED
NA
The Impacts of Theta-burst Stimulation on Children and Adolescents With Autism Spectrum Disorder
NCT03621189
COMPLETED
NA